Author

Evie Fitzsimons

University College London

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Approach:benchmark study· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Kwee YongiD· 2 shared Alessandro LaganàiD· 1 shared Andreas TrumppiD· 1 shared Angela Hamblin· 1 shared Anjan ThakurtaiD· 1 shared Anna D. MetzleriD· 1 shared Antonia SchachiD· 1 shared Benny ChainiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Kwee YongORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Sequential acquisition of 1p31.1-p12 LOH and 1q Gain is a common double-hit event in relapsed/refractory myeloma

Naser Ansari‐Pour, Sarah Gooding, Mohammad H. Kazeroun, Seyed Alireza Hasheminasab, Evie Fitzsimons, Selina J Chavda, Alessandro Laganà, Erin Flynt, Udo C. T. Oppermann, Karthik Ramasamy, Kwee Yong, Angela Hamblin, Jill Corre, Hervé Avet‐Loiseau, Nikhil C. Munshi, , Anjan Thakurta

The paper identifies a therapy-driven genomic double-hit (1pCEN LOH and 1q gain) in relapsed/refractory myeloma, associated with poor prognosis and clonal expansion.

bioRxiv · May 21, 2026 · PreprintCancer Biology

Conserved programs and specificities of T cells targeting hematological malignancies

Tim R. Wagner, Niklas Kehl, Simon Steiger, Tamara Boschert, Michael Kilian, Kane A. Foster, Gabrielle M. Hernandez, Claudia Ctortecka, Julius Michel, Antonia Schach, Julian Zoller, Anna D. Metzler, René Onken, Bruno Schönfelder, Simon Renders, , Mirco Friedrich

This study identifies rare tumor-reactive T cells and conserved antigen repertoires in multiple myeloma and acute myeloid leukemia, developing a TCR fitness model to predict immunotherapy response.

bioRxiv · Aug 7, 2025 · PreprintImmunology